Literature DB >> 34190027

Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis.

Arjun Gandhi1,2, Ayesha Shah1,2,3, Michael P Jones4, Natasha Koloski1,2,3, Nicholas J Talley5, Mark Morrison1,2,6, Gerald Holtmann1,2,3.   

Abstract

Several studies reported a potential role of methane producing archaea in the pathophysiology of irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). We conducted a systematic review and meta-analysis to assess the prevalence of methane positive small intestinal bacterial overgrowth (SIBO) in IBS and IBD compared with controls. MEDLINE (PubMed) and Embase electronic databases were searched from inception until March 2021 for case-control and prevalence studies reporting SIBO in IBS and IBD. We extracted data from published studies and calculated pooled prevalence of SIBO in IBS or IBD, odds ratios (OR), and 95% CIs, utilizing a random effects model. The final dataset included 17 independent studies assessing the prevalence of methane positive SIBO in 1,653 IBS-patients and 713 controls, and 7 studies assessing the prevalence of methane positive SIBO in 626 IBD-patients and 497 controls, all utilizing breath test for SIBO diagnosis. Prevalence of methane positive SIBO in IBS and IBD was 25.0% (95% CI 18.8-32.4) and 5.6% (95% CI 2.6-11.8), respectively. Methane positive SIBO in IBS was not increased compared to controls (OR = 1.2, 95% CI 0.8-1.7, P = .37) but was significantly more prevalent in IBS-C as compared to IBS-D (OR = 3.1, 95% CI 1.7-5.6, P = .0001). The prevalence of methane-positive SIBO in patients with IBD was 3-fold lower at 7.4% (95% CI 5.4-9.8) compared to 23.5% (95% CI 19.8-27.5) in controls. The prevalence of methane positive SIBO was significantly lower in Crohn's disease as compared to ulcerative colitis, (5.3%, 95% CI 3.0-8.5 vs. 20.2%, 95% CI 12.8-29.4). This systematic review and meta-analysis suggests methane positivity on breath testing is positively associated with IBS-C and inversely with IBD. However, the quality of evidence is low largely due to clinical heterogeneity of the studies. Thus, causality is uncertain and further studies are required.

Entities:  

Keywords:  Irritable bowel syndrome; breath tests; inflammatory bowel disease; methane; small intestinal bacterial overgrowth

Mesh:

Substances:

Year:  2021        PMID: 34190027      PMCID: PMC8253120          DOI: 10.1080/19490976.2021.1933313

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  58 in total

Review 1.  Evaluating non-randomised intervention studies.

Authors:  J J Deeks; J Dinnes; R D'Amico; A J Sowden; C Sakarovitch; F Song; M Petticrew; D G Altman
Journal:  Health Technol Assess       Date:  2003       Impact factor: 4.014

2.  Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference.

Authors:  A Gasbarrini; G R Corazza; G Gasbarrini; M Montalto; M Di Stefano; G Basilisco; A Parodi; P Usai-Satta; P U Satta; P Vernia; C Anania; M Astegiano; G Barbara; L Benini; P Bonazzi; G Capurso; M Certo; A Colecchia; L Cuoco; A Di Sario; D Festi; C Lauritano; E Miceli; G Nardone; F Perri; P Portincasa; R Risicato; M Sorge; A Tursi
Journal:  Aliment Pharmacol Ther       Date:  2009-03-30       Impact factor: 8.171

3.  Relationship of cytokines, oxidative stress and GI motility with bacterial overgrowth in ulcerative colitis patients.

Authors:  Satya Vati Rana; Surendra Sharma; Jaspreet Kaur; Kaushal Kishore Prasad; Saroj Kant Sinha; Rakesh Kochhar; Aastha Malik; Rajesh Kumar Morya
Journal:  J Crohns Colitis       Date:  2014-01-21       Impact factor: 9.071

4.  Bias in meta-analysis detected by a simple, graphical test.

Authors:  M Egger; G Davey Smith; M Schneider; C Minder
Journal:  BMJ       Date:  1997-09-13

5.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

6.  Small-Intestinal Bacterial Overgrowth is Associated With Concurrent Intestinal Inflammation But Not With Systemic Inflammation in Crohn's Disease Patients.

Authors:  José E R Ricci; Liliana A Chebli; Tarsila C D R Ribeiro; Antonio C S Castro; Pedro D Gaburri; Fabio H D L Pace; Kátia V B D Barbosa; Lincoln E V V D C Ferreira; Maria D C F Passos; Carla Malaguti; Álvaro H D A Delgado; Jacqueline D Campos; André R Coelho; Julio M F Chebli
Journal:  J Clin Gastroenterol       Date:  2018-07       Impact factor: 3.062

7.  Breath methane production in children with constipation and encopresis.

Authors:  S C Fiedorek; C L Pumphrey; H B Casteel
Journal:  J Pediatr Gastroenterol Nutr       Date:  1990-05       Impact factor: 2.839

Review 8.  Stability of human methanogenic flora over 35 years and a review of insights obtained from breath methane measurements.

Authors:  Michael D Levitt; Julie K Furne; Michael Kuskowski; John Ruddy
Journal:  Clin Gastroenterol Hepatol       Date:  2006-02       Impact factor: 11.382

9.  Duodenal bacterial load as determined by quantitative polymerase chain reaction in asymptomatic controls, functional gastrointestinal disorders and inflammatory bowel disease.

Authors:  Ayesha Shah; Nicholas J Talley; Natasha Koloski; Graeme A Macdonald; Bradley J Kendall; Erin R Shanahan; Marjorie M Walker; Simon Keely; Michael P Jones; Mark Morrison; Gerald J Holtmann
Journal:  Aliment Pharmacol Ther       Date:  2020-05-15       Impact factor: 8.171

10.  Protocol registration issues of systematic review and meta-analysis studies: a survey of global researchers.

Authors:  Gehad Mohamed Tawfik; Hoang Thi Nam Giang; Sherief Ghozy; Ahmed M Altibi; Hend Kandil; Huu-Hoai Le; Peter Samuel Eid; Ibrahim Radwan; Omar Mohamed Makram; Tong Thi Thu Hien; Mahmoud Sherif; As-Saba Hossain; Tai Luu Lam Thang; Livia Puljak; Hosni Salem; Tarek Numair; Kazuhiko Moji; Nguyen Tien Huy
Journal:  BMC Med Res Methodol       Date:  2020-08-25       Impact factor: 4.615

View more
  6 in total

1.  Small intestinal bacterial overgrowth in inflammatory bowel disease.

Authors:  Ayesha Shah; Gerald Holtmann
Journal:  Indian J Gastroenterol       Date:  2022-01-15

Review 2.  Methanogenic archaea in the human gastrointestinal tract.

Authors:  Christoph Hoegenauer; Heinz F Hammer; Alexander Mahnert; Christine Moissl-Eichinger
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-09-01       Impact factor: 73.082

Review 3.  Current and Future Approaches for Diagnosing Small Intestinal Dysbiosis in Patients With Symptoms of Functional Dyspepsia.

Authors:  Ayesha Shah; Nicholas J Talley; Gerald Holtmann
Journal:  Front Neurosci       Date:  2022-05-06       Impact factor: 5.152

4.  Evidence-Based and Emerging Diet Recommendations for Small Bowel Disorders.

Authors:  Anupam Rej; Michael D E Potter; Nicholas J Talley; Ayesha Shah; Gerald Holtmann; David Surendran Sanders
Journal:  Am J Gastroenterol       Date:  2022-04-08       Impact factor: 12.045

5.  Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association.

Authors:  Uday C Ghoshal; Sanjeev Sachdeva; Ujjala Ghoshal; Asha Misra; Amarender Singh Puri; Nitesh Pratap; Ayesha Shah; M Masudur Rahman; Kok Ann Gwee; Victoria P Y Tan; Tahmeed Ahmed; Yeong Yeh Lee; B S Ramakrishna; Rupjyoti Talukdar; S V Rana; Saroj K Sinha; Minhu Chen; Nayoung Kim; Gerald Holtmann
Journal:  Indian J Gastroenterol       Date:  2022-10-10

Review 6.  Gut Non-Bacterial Microbiota: Emerging Link to Irritable Bowel Syndrome.

Authors:  Ao Liu; Wenkang Gao; Yixin Zhu; Xiaohua Hou; Huikuan Chu
Journal:  Toxins (Basel)       Date:  2022-08-29       Impact factor: 5.075

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.